Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-19 derived from a/guangdong-maonan/swl1536/2019), haemagglutininum influenzae a (h3n2) (virus souche a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019), haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) - suspension zur injektion in einer fertigspritze - haemagglutininum influenzae a (h1n1) (virus souche a/guangdong-maonan/swl1536/2019 (h1n1)-pdm09: reassortant virus cnic-19 derived from a/guangdong-maonan/swl1536/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus souche a/hong kong/2671/2019 (h3n2)-like: reassortant virus ivr-208 derived from a/hong kong/2671/2019) 15 µg, haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. - aktive immunisierung gegen influenza, ab dem 6. monat - impfstoffe

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi pasteur europe - influenza-virus, inaktiviert, tetravalent - injektionssuspension in fertigspritze - influenza-virus, inaktiviert, tetravalent - influenza, inactivated, split virus or surface antigen

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus-souche a/michigan/45/2015 (h1n1)-like: reassortanten virus nymc x-275), haemagglutininum influenzae a (h3n2) (virus-souche a/singapore/infimh-16-0019/2016 (h3n2)-like: reassortanten virus ivr-186), haemagglutininum influenzae b (virus-souche b/colorado/06/2017-wie: reassortanten virus nymc bx-69a, abgeleitet von b/maryland/15/2016 (victoria-linie)) - suspension zur injektion in einer fertigspritze - haemagglutininum influenzae a (h1n1) (virus souche a/michigan/45/2015 (h1n1)-like: reassortant virus nymc x-275) 15 µg, haemagglutininum influenzae a (h3n2) (virus souche a/singapore/infimh-16-0019/2016 (h3n2)-like: reassortant virus ivr-186) 15 µg, haemagglutininum influenzae b (virus souche b/colorado/06/2017-like: reassortant virus nymc bx-69a derived from b/maryland/15/2016 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013-like: reassortant virus wild type derived from b/phuket/3073/2013 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. - aktive immunisierung gegen influenza, ab dem 6. monat - impfstoffe

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - suspension zur injektion in einer fertigspritze

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus-souche a/michigan/45/2015 (h1n1)-like: reassortanten virus nymc x-275), haemagglutininum influenzae a (h3n2) (virus-souche a/hongkong/4801/2014 (h3n2)-like: reassortanten virus nymc x-263b), haemagglutininum influenzae b (virus-souche b/brisbane/60/2008) - injizierbare suspension - haemagglutininum influenzae a (h1n1) (virus-souche a/michigan/45/2015 (h1n1)-like: reassortanten virus nymc x-275) 15 µg, haemagglutininum influenzae a (h3n2) (virus-souche a/hongkong/4801/2014 (h3n2)-like: reassortanten virus nymc x-263b) 15 µg, haemagglutininum influenzae b (virus-souche b/brisbane/60/2008) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, der rest: formaldehydum max. 100 µg, octoxinolum-9 max. 500 µg, ovalbuminum max. 0,05 µg, kunststoff nein, neomycinum nichts, wasser zu iniectabilia q.s. zu der suspension 0,5 ml. - aktive immunisierung gegen influenza, ab dem 6. monat - impfstoffe

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - suspension injectable

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus-souche a/michigan/45/2015 (h1n1)-like: reassortanten virus nymc x-275), haemagglutininum influenzae a (h3n2) (virus-souche a/singapore/infimh-16-0019/2016 (h3n2)-like: reassortanten virus ivr-186), haemagglutininum influenzae b (virus-souche b/colorado/06/2017-wie: reassortanten virus nymc bx-69a, abgeleitet von b/maryland/15/2016) - injizierbare suspension - haemagglutininum influenzae a (h1n1) (virus souche a/michigan/45/2015 (h1n1)-like: reassortant virus nymc x-275) 15 µg, haemagglutininum influenzae a (h3n2) (virus souche a/singapore/infimh-16-0019/2016 (h3n2)-like: reassortant virus ivr-186) 15 µg, haemagglutininum influenzae b (virus souche b/colorado/06/2017-like: reassortant virus nymc bx-69a derived from b/maryland/15/2016) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residui: formaldehydum max. 30 µg, octoxinolum-9 max. 200 µg, neomycinum max. 7.5 pg, ovalbuminum max. 50 ng, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen influenza, ab dem 6. monat - impfstoffe

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - injizierbare suspension

Deutschland - Deutsch - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

basf se - 480 g/l bentazon (524 g/l natrium-salz) - wasserlösliches konzentrat - herbizid

Deutschland - Deutsch - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

basf se - 333 g/l bentazon (364 g/l natrium-salz); 233 g/l dichlorprop-p (271 g/l kalium-salz) - wasserlösliches konzentrat - herbizid